Form 4: Elanco Animal Health Director Receives Stock Award

Elanco Animal Health director Lawrence Kurzius received 18,169 shares of common stock as part of an annual equity award.

Summary

• Lawrence Kurzius, a director at Elanco Animal Health, received 18,169 shares of common stock.
• The shares were granted as part of an annual equity award for non-employee members of the Board of Directors.
• The transaction occurred on November 29, 2024.
• Following the transaction, Mr. Kurzius directly owns 91,459 shares of Elanco stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns interests. There is no indication of any negative or unexpected events.

Positives

• The grant of stock units aligns the interests of the non-employee directors with the company's performance.
• The equity award is a standard practice for compensating board members.

Industry Context

This type of equity award is a common practice in corporate governance to compensate and incentivize board members, aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Granting stock options or restricted stock units to board members is a standard practice across publicly traded companies.
• The amount of equity granted is generally determined by the company's compensation policy and the board member's role and responsibilities.
• Companies like Zoetis and IDEXX Laboratories also use similar equity-based compensation for their board members.

Stakeholder Impact

• The stock grant aligns the interests of the director with those of the shareholders.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elanco Animal Health, stock award, equity compensation, director, Lawrence Kurzius, board of directors, share ownership